Last reviewed · How we verify
NCT05987436
Effect of Aerobic Exercise in Patients With Essential Hypertension
trial testing Supervised Aerobic Exercise in Aerobic Exercise in 138 participants. Completed in 1 December 2019.
1 April 2019
Quick facts
| Lead sponsor | TC Erciyes University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 138 |
| Start date | 1 November 2017 |
| Primary completion | 1 April 2019 |
| Estimated completion | 1 December 2019 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Supervised Aerobic Exercise
Conditions studied
- Aerobic Exercise — all drugs for Aerobic Exercise →
- Essential Hypertension — all drugs for Essential Hypertension →
Sponsor
TC Erciyes University
Who can join
Adults 18 to 75, any sex, with Aerobic Exercise or Essential Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to evaluate the effects of a supervised aerobic exercise training program on weight loss, functional capacity, quality of life (QoL), and depression levels in patients with essential hypertension.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05987436
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Supervised Aerobic Exercise
Trials testing the same drug.
- NCT07486557 — Cistanche Deserticola Extract Combined With Aerobic Exercise Improves Body Composition, Insulin Resistance and Inflammat · NA · completed
- NCT02969824 — Post-acute Structured Exercise Following Sport Concussion · NA · terminated
Other recruiting trials for Aerobic Exercise
Currently open trials in the same condition.
- NCT07469540 — Effects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid Arth · NA · recruiting
- NCT07216495 — Pilot Study of Aerobic Exercise During Immune Checkpoint Inhibitor Therapy in Early-Stage TNBC · NA · recruiting
- NCT07002125 — Whole Body Vibration Therapy in Individuals With Type 2 Diabetes · NA · recruiting
- NCT07070791 — Combined Upper Extremity Resistance and Aerobic Exercise Training in Patients With Breast Cancer · NA · recruiting
- NCT07070778 — Arterial Stiffness in Individuals With Breast Cancer · NA · recruiting
Other TC Erciyes University trials
Trials by the same sponsor.
- NCT07007858 — Effects of High-Velocity Passive Stretch on Spasticity, Function, and Muscle Structure in Spastic CP Children · NA · enrolling by invitation
- NCT07529964 — MMP-2/3 and Periapical Healing Outcomes · not yet recruiting
- NCT07526831 — Comparison of the Analgesic Efficacy of Adductor Canal Block and Combined Adductor Canal Block Plus IPACK Block in Knee · recruiting
- NCT07371806 — EFFETCS OF MİNDFULNESS-BASED STRESS REDUCTION İN WOMEN WİTH CORONARY ARTERY DİSEASE · NA · not yet recruiting
- NCT07499947 — Predicting Spinal Hypotension in Cesarean Section · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05987436 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TC Erciyes University
- Last refreshed: 14 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05987436.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing